Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier

Documents similaires

• Polycythemia caused by erythropoietin‐producing hemangiosarcoma
  par: Osamu Imataki, et autres
  Publié: (2024)
• Metabolic pitfall of pseudoprogression after epcoritamab treatment
  par: Osamu Imataki, et autres
  Publié: (2024)
• Acquired glucose‐6‐phosphate dehydrogenase deficiency after allogeneic stem‐cell transplantation
  par: Quentin Vô, et autres
  Publié: (2024)
• Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
  par: B. Linder Grønvold, et autres
  Publié: (2024)
• Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation
  par: Toshiki Terao, et autres
  Publié: (2024)